Generics - GlaxoSmithKline

Filter

Current filters:

GlaxoSmithKline

Popular Filters

1620 to 1643 of 1643 results

US FDA consults on user fee program for biosimilar and interchangeable biologicals

10-05-2011

The US Food and Drug Administration is requesting input from stakeholders and the public relating to…

BiotechnologyGenericsNorth AmericaPharmaceuticalRegulation

India set to become global leader in APIs industry

10-05-2011

Low-cost manufacturing facilities and abundant talent pool will drive the growth of India in the global…

Asia-PacificGenericsMarkets & Marketing

Growth in Canadian drug spending slows to lowest rate since 1996

09-05-2011

Although drugs remain an important cost driver in Canada’s health system, growth in spending has…

GenericsHealthcareNorth AmericaPharmaceuticalPricing

Nigerian government plans local production of anti-malaria drugs

06-05-2011

To further reduce the cost of anti-malaria drug and reduce malaria incidence to the barest minimum, the…

GenericsMarkets & MarketingPharmaceuticalPoliticsRest of the WorldTropical diseases

Australian generic drugmakers welcome IP law to encourage R&D investment

06-05-2011

Members of Australia’s Generic Medicines Industry Association (GMiA) have strongly welcomed the…

Asia-PacificGenericsPatentsPharmaceutical

Chile remains on USTR Priority Watch list

06-05-2011

The Office of the United States Trade Representative (USTR) released its annual Special 301 Report on…

GenericsLegalNorth AmericaPatentsPharmaceuticalSouth America

Asthma pill more user-friendly than inhalers - and no less effective

06-05-2011

Rarely prescribed asthma drug in tablet form are easier to use and just as effective as conventional…

AccolateGlaxoSmithKlineMerck & CoPharmaceuticalResearchRespiratory and PulmonarySingulair

US FTC finds 60% rise in pharma pay-for-delay deals; flawed understanding says GPhA

05-05-2011

Pharmaceutical companies in the USA struck an unprecedented number of deals in fiscal year 2010 in which…

GenericsLicensingNorth AmericaPharmaceutical

Non-Hodgkins lymphoma drug market set to more than double by 2019

05-05-2011

Driven by the launches of premium-priced therapies, the non-Hodgkin’s lymphoma drug market will…

ArzerraGlaxoSmithKlineMarkets & MarketingOncologyPharmaceuticalRituxanrituximabRoche

Teva to buy Japanese generic drugmaker Taiyo?

04-05-2011

According to Japan’s leading financial newspaper, The Nikkei, Israeli generics drug giant Teva Pharmaceutical…

Asia-PacificGenericsMergers & AcquisitionsTaiyo PharmaTeva Pharmaceutical Industries

Mylan's 1st-qtr 2011 adjusted diluted EPS up 22%, in line with forecasts

04-05-2011

US generics group Mylan (Nasdaq: MYL) reported that total revenues for the quarter ended March 31, 2011…

FinancialGenericsMylan Laboratories

European Commission opens investigation against Cephalon and Teva

03-05-2011

The European Commission has opened a formal antitrust investigation to assess whether an agreement between…

CephalonEuropeGenericsLegalTeva Pharmaceutical Industries

Hikma must sell two drugs as condition of Baxter Healthcare acquisition, says US antitrust body

29-04-2011

The USA’s Federal Trade Commission will require Jordan-based drugmaker Hikma Pharmaceuticals (LSE:…

Baxter HealthcareGenericsHikma PharmaceuticalsLegalMergers & Acquisitions

GlaxoSmithKline 1st-qtr 2011 sales and earnings down but firm back in the black; Lovaza subpoena

28-04-2011

After revealing a more than $1 billion loss for the fourth quarter of 2010 as a result of legal charges…

FinancialGlaxoSmithKlineLegalLovazaPharmaceutical

Generic drug sales in Brazil leapt 53% in 2010; double-digit growth forecast the next two years

28-04-2011

In Brazil, sales last year of generic drugs - which are nearly identical reproductions of off-patent…

GenericsMarkets & MarketingPatentsSouth America

Watson 1st-qtr 2011 net revenue Increases 2.3% to $877 million

28-04-2011

USA-based generics and specialty drugmaker Watson Pharmaceuticals (NYSE: WPI) reported net revenue of…

FinancialGenericsPharmaceuticalWatson Pharmaceuticals

Hospira’s first-quarter 2011 results beat forecasts, helped by generic Taxotere

27-04-2011

Specialty drugmaker Hospira (NYSE: HSP) yesterday reported results for the first quarter ended March…

FinancialGenericsHospiraTaxotere

Kaketsuken initiates second trial of flu vaccine using Vivalis EB66 cell line

26-04-2011

Japan’s Chemo-Sero-Therapeutic Research Institute (Kaketsuken) has initiated the first human injection…

GlaxoSmithKlineKaketsukenPharmaceuticalResearchRespiratory and PulmonaryVaccinesVivalis

1620 to 1643 of 1643 results

Back to top